ロード中...

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?

Aspirin and heparin are widely used to reduce the risk of recurrent pregnancy loss in women with antiphospholipid syndrome. This practice is based on only a few intervention studies, and uncertainty regarding benefits and risk remains. In this case‐based review, we summarize the available evidence a...

詳細記述

保存先:
書誌詳細
出版年:J Thromb Haemost
主要な著者: Hamulyák, Eva N., Scheres, Luuk J. J., Goddijn, Mariëtte, Middeldorp, Saskia
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252114/
https://ncbi.nlm.nih.gov/pubmed/33687789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15290
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!